These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 33183460)
1. Preparation of Simvastatin Loaded Nanostructured Lipid Carriers and Its Therapeutic Effect on Patients with Severe Acute Lung Injury. Yan X; Zhang W; Cheng X; Hou L J Nanosci Nanotechnol; 2021 Feb; 21(2):1184-1189. PubMed ID: 33183460 [TBL] [Abstract][Full Text] [Related]
2. Targeting delivery of simvastatin using ICAM-1 antibody-conjugated nanostructured lipid carriers for acute lung injury therapy. Li SJ; Wang XJ; Hu JB; Kang XQ; Chen L; Xu XL; Ying XY; Jiang SP; Du YZ Drug Deliv; 2017 Nov; 24(1):402-413. PubMed ID: 28165814 [TBL] [Abstract][Full Text] [Related]
3. Anti-ICAM-1 antibody-modified nanostructured lipid carriers: a pulmonary vascular endothelium-targeted device for acute lung injury therapy. Li S; Chen L; Wang G; Xu L; Hou S; Chen Z; Xu X; Wang X; Liu F; Du YZ J Nanobiotechnology; 2018 Dec; 16(1):105. PubMed ID: 30594254 [TBL] [Abstract][Full Text] [Related]
4. Simvastatin-loaded nanostructured lipid carriers attenuate the atherogenic risk of erythrocytes in hyperlipidemic rats. Harisa GI; Alomrani AH; Badran MM Eur J Pharm Sci; 2017 Jan; 96():62-71. PubMed ID: 27613383 [TBL] [Abstract][Full Text] [Related]
6. Simvastatin-Loaded Nanostructured Lipid Carriers as Topical Drug Delivery System for Wound Healing Purposes: Preparation, Characterization, and Mousavi-Simakani SM; Azadi A; Tanideh N; Omidifar N; Ghasemiyeh P; Mohammadi-Samani S Adv Pharm Bull; 2023 Nov; 13(4):761-771. PubMed ID: 38022815 [TBL] [Abstract][Full Text] [Related]
7. Nanostructured lipid carriers loaded with simvastatin: effect of PEG/glycerides on characterization, stability, cellular uptake efficiency and in vitro cytotoxicity. Safwat S; Ishak RAH; Hathout RM; Mortada ND Drug Dev Ind Pharm; 2017 Jul; 43(7):1112-1125. PubMed ID: 28276784 [TBL] [Abstract][Full Text] [Related]
8. PEGylated nanostructured lipid carriers loaded with 10-hydroxycamptothecin: an efficient carrier with enhanced anti-tumour effects against lung cancer. Zhang X; Gan Y; Gan L; Nie S; Pan W J Pharm Pharmacol; 2008 Aug; 60(8):1077-87. PubMed ID: 18644200 [TBL] [Abstract][Full Text] [Related]
9. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s). Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192 [TBL] [Abstract][Full Text] [Related]
10. Intranasal artesunate-loaded nanostructured lipid carriers: A convenient alternative to parenteral formulations for the treatment of severe and cerebral malaria. Agbo CP; Ugwuanyi TC; Ugwuoke WI; McConville C; Attama AA; Ofokansi KC J Control Release; 2021 Jun; 334():224-236. PubMed ID: 33894303 [TBL] [Abstract][Full Text] [Related]
11. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery. Li H; Chen M; Su Z; Sun M; Ping Q Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421 [TBL] [Abstract][Full Text] [Related]
12. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery. Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691 [TBL] [Abstract][Full Text] [Related]
13. Redox markers and inflammation are differentially affected by atorvastatin, pravastatin or simvastatin administered before endotoxin-induced acute lung injury. Melo AC; Valença SS; Gitirana LB; Santos JC; Ribeiro ML; Machado MN; Magalhães CB; Zin WA; Porto LC Int Immunopharmacol; 2013 Sep; 17(1):57-64. PubMed ID: 23747588 [TBL] [Abstract][Full Text] [Related]
14. Rifampicin loaded mannosylated cationic nanostructured lipid carriers for alveolar macrophage-specific delivery. Song X; Lin Q; Guo L; Fu Y; Han J; Ke H; Sun X; Gong T; Zhang Z Pharm Res; 2015 May; 32(5):1741-51. PubMed ID: 25407545 [TBL] [Abstract][Full Text] [Related]
15. Lung cancer combination therapy: doxorubicin and β-elemene co-loaded, pH-sensitive nanostructured lipid carriers. Cao C; Wang Q; Liu Y Drug Des Devel Ther; 2019; 13():1087-1098. PubMed ID: 31118562 [No Abstract] [Full Text] [Related]
16. Enhanced antifungal activity of voriconazole-loaded nanostructured lipid carriers against Tian B; Yan Q; Wang J; Ding C; Sai S Int J Nanomedicine; 2017; 12():7131-7141. PubMed ID: 29026306 [No Abstract] [Full Text] [Related]
17. Anti-inflammatory activity of injectable dexamethasone acetate-loaded nanostructured lipid carriers. Xu X; Zhao C; Yang H; Jian Y; Zhang Z; Huang Y Drug Deliv; 2011; 18(7):485-92. PubMed ID: 21692681 [TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid modified nanostructured lipid carriers for transdermal bupivacaine delivery: In vitro and in vivo anesthesia evaluation. Yue Y; Zhao D; Yin Q Biomed Pharmacother; 2018 Feb; 98():813-820. PubMed ID: 29571251 [TBL] [Abstract][Full Text] [Related]
19. Transdermal drug delivery of triptolide-loaded nanostructured lipid carriers: Preparation, pharmacokinetic, and evaluation for rheumatoid arthritis. Gu Y; Tang X; Yang M; Yang D; Liu J Int J Pharm; 2019 Jan; 554():235-244. PubMed ID: 30423415 [TBL] [Abstract][Full Text] [Related]
20. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration. Song A; Zhang X; Li Y; Mao X; Han F Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]